...partnered to develop companion diagnostics. The partnership will focus on cardiac disease, cancer and inflammation. Singulex...
...terms. Singulex Inc. , Alameda, Calif. Qiagen N.V. (Xetra:QIA; NASDAQ:QGEN), Venlo, the Netherlands Business: Pharmacogenetics Nora Weintraub Qiagen N.V. Singulex Inc....

...rights to use and sell Singulex’s SMC diagnostic technology to screen donor blood and plasma. Singulex...
...said disease indications and sales structure will be developed during the course of the partnership. Singulex Inc....

...board since 1999 and currently serves on several other corporate boards, including diagnostic tool company Singulex Inc....

...system will combine Singulex's single molecule counting technology with Tecan's Freedom EVO liquid handling platform. Singulex...
...early as 2016. Singulex declined to disclose financial details, and Tecan could not be reached. Singulex Inc....

...Diagnostic, Supply/Service Date completed: 6/1/13 Type: Venture financing Raised: $15 million Investors: Existing investors Note: Singulex...

...Bank are providing the facility. Late last year, Singulex withdrew its IPO, citing market conditions. Singulex...

...Diagnostic, Supply/Service Date announced: 12/28/12 Type: IPO Underwriters: UBS; Piper Jaffray; William Blair; Leerink Note: Singulex...

...A $16 price would have raised $70 million and valued the company at $245.5 million. Singulex...
...inflammatory, lipid and metabolic tests. At June 30, the company had $7.9 million in cash. Singulex...